Decoy receptor 3, a novel inflammatory marker, and mortality in hemodialysis patients

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 8, 2012, Pages 1257-1265

  Hung, Szu Chun ^a   Hsu, Ta Wei ^b   Lin, Yao Ping ^c   Tarng, Der Cherng ^b,c  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; DECOY RECEPTOR 3; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CACHEXIA; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEATH; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HAZARD RATIO; HEART INFARCTION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORTALITY; PREDICTIVE VALUE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SEPSIS; SMOKING; STROKE; SYSTOLIC BLOOD PRESSURE;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; KAPLAN-MEIER ESTIMATE; KIDNEY DISEASES; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 6B; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; TAIWAN; TIME FACTORS; UP-REGULATION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84864810500     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.08410811     Document Type: Article

References (29)

1. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32 [Suppl 3]: S112-S119, 1998
2. Carrero JJ, Stenvinkel P: Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: A hypothesis proposal. Clin J Am Soc Nephrol 4[Suppl 1]: S49-S55, 2009
3. Kalantar-Zadeh K: Inflammatory marker mania in chronic kidney disease: Pentraxins at the crossroad of universal soldiers of inflammation. Clin J Am Soc Nephrol 2: 872-875, 2007
4. Pitti RM, Marsters SA, Lawrence DA, Roy M, Kischkel FC, Dowd P, Huang A, Donahue CJ, Sherwood SW, Baldwin DT, Godowski PJ, Wood WI, Gurney AL, Hillan KJ, Cohen RL, Goddard AD, Botstein D, Ashkenazi A: Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 396: 699-703, 1998
5. Zhang J, Salcedo TW, Wan X, Ullrich S, Hu B, Gregorio T, Feng P, Qi S, ChenH, Cho YH, Li Y, Moore PA, Wu J: Modulation of T-cell responses to alloantigens by TR6/DcR3. J Clin Invest 107: 1459-1468, 2001
6. Shi G, Wu Y, Zhang J, Wu J: Death decoy receptor TR6/DcR3 inhibits T cell chemotaxis in vitro and in vivo. J Immunol 171: 3407-3414, 2003
7. Chang YC, Hsu TL, LinHH, Chio CC, Chiu AW, Chen NJ, Lin CH, Hsieh SL: Modulation of macrophage differentiation and activation by decoy receptor 3. J Leukoc Biol 75: 486-494, 2004
8. Ka SM, Sytwu HK, Chang DM, Hsieh SL, Tsai PY, Chen A: Decoy receptor 3 ameliorates an autoimmune crescentic glomerulonephritismodel in mice. J AmSoc Nephrol 18: 2473-2485, 2007
9. Libby P, Theroux P: Pathophysiology of coronary artery disease. Circulation 111: 3481-3488, 2005
10. Yang CR, Hsieh SL, Ho FM, LinWW: Decoy receptor 3 increases monocyte adhesion to endothelial cells via NF-kappa B-dependent up-regulation of intercellular adhesionmolecule-1, VCAM-1, and IL-8 expression. J Immunol 174: 1647-1656, 2005
11. Blankenberg S, Barbaux S, Tiret L: Adhesion molecules and atherosclerosis. Atherosclerosis 170: 191-203, 2003
12. Chen J, Zhang L, Kim S: Quantification and detection of DcR3, a decoy receptor in TNFR family. J Immunol Methods 285: 63-70, 2004
13. Daugirdas JT: Second generation logarithmic estimates of singlepool variable volume Kt/V: An analysis of error. J AmSoc Nephrol 4: 1205-1213, 1993
14. Heagerty PJ, Zheng Y: Survival model predictive accuracy and ROC curves. Biometrics 61: 92-105, 2005
15. Posada D, Buckley TR: Model selection and model averaging in phylogenetics: Advantages of akaike information criterion and bayesian approaches over likelihood ratio tests. Syst Biol 53: 793-808, 2004
16. Yu KY, Kwon B, Ni J, Zhai Y, Ebner R, Kwon BS: A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J Biol Chem274: 13733-13736, 1999
17. Migone TS, Zhang J, Luo X, Zhuang L, Chen C, Hu B, Hong JS, Perry JW, Chen SF, Zhou JX, Cho YH, Ullrich S, Kanakaraj P, Carrell J, Boyd E, Olsen HS, Hu G, Pukac L, Liu D, Ni J, Kim S, Gentz R, Feng P, Moore PA, Ruben SM, Wei P: TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 16: 479-492, 2002
18. Lin WW, Hsieh SL: Decoy receptor 3: A pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer. Biochem Pharmacol 81: 838-847, 2011
19. Stenvinkel P, Barany P, HeimburgerO, Pecoits-Filho R, Lindholm B: Mortality, malnutrition and atherosclerosis in ESRD: What is the role of interleukin-6? Kidney Int Suppl 80: 103-108, 2002
20. Tripepi G, Mallamaci F, Zoccali C: Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: Searching for the best risk marker by multivariate modeling. J AmSoc Nephrol 16[Suppl 1]: S83-S88, 2005
21. Fong PF: Elucidation of Signaling Pathways Involving in Interleukin-6 (IL-6) InducedDecoy Receptor 3 (DcR3) Expression in a Colorectal Cancer Cell Line [Master's Thesis]. Taipei, National Yang-Ming University, 2009
22. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V: Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link? Atherosclerosis 148: 209-214, 2000
23. Kim S, McAuliffe WJ, Zaritskaya LS, Moore PA, Zhang L, Nardelli B: Selective induction of tumor necrosis receptor factor 6/decoy receptor 3 release by bacterial antigens in human monocytes and myeloid dendritic cells. Infect Immun 72: 89-93, 2004
24. Ortiz A, Lorz C, Justo P, Catalán MP, Egido J: Contribution of apoptotic cell death to renal injury. J Cell Mol Med 5: 18-32, 2001
25. Tateishi K, Miura Y, Hayashi S, Takahashi M, Kurosaka M: DcR3 protects THP-1 macrophages from apoptosis by increasing integrin a4. Biochem Biophys Res Commun 389: 593-598, 2009
26. Han B, Bojalil R, Amezcua-Guerra LM, Springall R, Valderrama-Carvajal H, WuJ, LuoH: DcR3 as a diagnostic parameter and risk factor for systemic lupus erythematosus. Int Immunol 20: 1067-1075, 2008
27. Chen CY, Yang KY, Chen MY, Chen HY, LinMT, Lee YC, Perng RP, Hsieh SL, Yang PC, Chou TY: Decoy receptor 3 levels in peripheral blood predict outcomes of acute respiratory distress syndrome. Am J Respir Crit Care Med 180: 751-760, 2009
28. GutiérrezOM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Jüppner H, Wolf M: Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359: 584-592, 2008
29. Zhan C, Patskovsky Y, Yan Q, Li Z, Ramagopal U, Cheng H, Brenowitz M, Hui X, Nathenson SG, Almo SC: Decoy strategies: The structure of TL1A:DcR3 complex. Structure 19: 162-171, 2011